Cargando…

Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction

Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshiro, Satoshi, Tada, Tatsuya, Mizutani, Naeko, Funatogawa, Keiji, Sekiguchi, Jun-ichiro, Takahashi, Masao, Kirikae, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840401/
https://www.ncbi.nlm.nih.gov/pubmed/33526960
http://dx.doi.org/10.1016/j.idairyj.2021.105002
_version_ 1783643568260251648
author Oshiro, Satoshi
Tada, Tatsuya
Mizutani, Naeko
Funatogawa, Keiji
Sekiguchi, Jun-ichiro
Takahashi, Masao
Kirikae, Teruo
author_facet Oshiro, Satoshi
Tada, Tatsuya
Mizutani, Naeko
Funatogawa, Keiji
Sekiguchi, Jun-ichiro
Takahashi, Masao
Kirikae, Teruo
author_sort Oshiro, Satoshi
collection PubMed
description Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The full-length and partial-length SARS-CoV-2 S, N, a recombinant protein of the receptor binding domain (RBD) and nine peptides covering the receptor binding motif (RBM) of S were prepared. Direct enzyme-linked immunosorbent assays were conducted using these recombinant proteins and peptides as coating antigens and revealed the IgG enriched fraction contained antibodies against partial-length S [amino acids (aa) 177–512, 288–512, 348–578, 387–516 and 408–664], full-length N (aa 1–419) and partial-length N (aa 1–120, 111–220, 1–220 and 210–419), two RBD peptides, covering aa 427–446 and 502–520 of S, and recombinant RBD of S. These results indicate IgG enriched fraction contains antibodies against SARS-CoV-2.
format Online
Article
Text
id pubmed-7840401
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78404012021-01-28 Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction Oshiro, Satoshi Tada, Tatsuya Mizutani, Naeko Funatogawa, Keiji Sekiguchi, Jun-ichiro Takahashi, Masao Kirikae, Teruo Int Dairy J Short Communication Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The full-length and partial-length SARS-CoV-2 S, N, a recombinant protein of the receptor binding domain (RBD) and nine peptides covering the receptor binding motif (RBM) of S were prepared. Direct enzyme-linked immunosorbent assays were conducted using these recombinant proteins and peptides as coating antigens and revealed the IgG enriched fraction contained antibodies against partial-length S [amino acids (aa) 177–512, 288–512, 348–578, 387–516 and 408–664], full-length N (aa 1–419) and partial-length N (aa 1–120, 111–220, 1–220 and 210–419), two RBD peptides, covering aa 427–446 and 502–520 of S, and recombinant RBD of S. These results indicate IgG enriched fraction contains antibodies against SARS-CoV-2. Elsevier Ltd. 2021-06 2021-01-28 /pmc/articles/PMC7840401/ /pubmed/33526960 http://dx.doi.org/10.1016/j.idairyj.2021.105002 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Oshiro, Satoshi
Tada, Tatsuya
Mizutani, Naeko
Funatogawa, Keiji
Sekiguchi, Jun-ichiro
Takahashi, Masao
Kirikae, Teruo
Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title_full Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title_fullStr Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title_full_unstemmed Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title_short Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
title_sort presence of antibodies against sars-cov-2 spike protein in bovine whey igg enriched fraction
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840401/
https://www.ncbi.nlm.nih.gov/pubmed/33526960
http://dx.doi.org/10.1016/j.idairyj.2021.105002
work_keys_str_mv AT oshirosatoshi presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT tadatatsuya presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT mizutaninaeko presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT funatogawakeiji presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT sekiguchijunichiro presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT takahashimasao presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction
AT kirikaeteruo presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction